Total Payments
$2,095
2024 Payments
$391.87
Companies
18
Transactions
53
Medicare Patients
5,317
Medicare Billing
$637,690
Payment Breakdown by Category
Food & Beverage$2,045 (97.6%)
Education$49.58 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,045 | 51 | 97.6% |
| Education | $49.58 | 2 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $925.90 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $268.12 | 7 | $0 (2021) |
| ABBVIE INC. | $178.73 | 4 | $0 (2024) |
| MAYNE PHARMA INC. | $121.75 | 5 | $0 (2022) |
| Lupin Inc. | $119.67 | 1 | $0 (2019) |
| CooperSurgical, Inc. | $75.98 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $71.45 | 3 | $0 (2024) |
| Hologic, LLC | $59.52 | 4 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $46.18 | 2 | $0 (2020) |
| Astellas Pharma US Inc | $42.10 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $391.87 | 14 | Amgen Inc. ($193.61) |
| 2023 | $242.80 | 7 | Amgen Inc. ($120.59) |
| 2022 | $131.23 | 6 | MAYNE PHARMA INC. ($121.75) |
| 2021 | $190.51 | 4 | Amgen Inc. ($124.15) |
| 2020 | $41.76 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($23.61) |
| 2019 | $395.43 | 5 | Amgen Inc. ($124.77) |
| 2018 | $453.16 | 7 | Amgen Inc. ($243.11) |
| 2017 | $247.89 | 8 | Merck Sharp & Dohme Corporation ($104.70) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Biological | ||||||
| 11/26/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: WOMENS HEALTH | ||||||
| 10/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Bone Health | ||||||
| 10/14/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Hematology | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Bone Health | ||||||
| 09/30/2024 | MILLICENT US INC | — | Education | In-kind items and services | $26.70 | General |
| 09/10/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Bone Health | ||||||
| 08/27/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: Bone Health | ||||||
| 08/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/08/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: WOMENS HEALTH | ||||||
| 05/24/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: WOMENS HEALTH | ||||||
| 02/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/11/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Biological | ||||||
| 09/14/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: ETONOGESTREL | ||||||
| 08/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: INSOMNIA | ||||||
| 05/10/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.69 | General |
| 04/27/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: ETONOGESTREL | ||||||
| 02/08/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.59 | General |
| Category: Bone Health | ||||||
| 12/13/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $28.15 | General |
| 07/29/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: ETONOGESTREL | ||||||
| 07/08/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $19.63 | General |
| 06/29/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $30.37 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,340 | 5,881 | $1.0M | $191,904 |
| 2022 | 11 | 1,134 | 4,436 | $694,289 | $154,242 |
| 2021 | 9 | 1,322 | 5,001 | $621,766 | $173,850 |
| 2020 | 10 | 1,521 | 2,061 | $463,943 | $117,693 |
Total Patients
5,317
Total Services
17,379
Medicare Billing
$637,690
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 48 | 4,320 | $561,600 | $79,958 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 480 | 518 | $238,280 | $55,095 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 219 | 351 | $105,300 | $27,004 | 25.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 279 | 280 | $19,600 | $12,732 | 65.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $27,965 | $6,664 | 23.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 40 | 44 | $27,042 | $5,053 | 18.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 68 | 140 | $26,600 | $1,796 | 6.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 29 | 29 | $4,669 | $1,471 | 31.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 27 | 27 | $4,104 | $1,277 | 31.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 86 | $1,720 | $722.40 | 42.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 39 | $1,950 | $132.99 | 6.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 49 | 3,240 | $327,000 | $56,213 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 407 | 441 | $187,350 | $49,566 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 270 | $77,360 | $22,309 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $29,435 | $7,505 | 25.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 147 | 147 | $19,350 | $6,638 | 34.3% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 40 | 42 | $24,416 | $4,768 | 19.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 60 | 60 | $9,654 | $3,151 | 32.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 62 | 62 | $9,364 | $3,066 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 57 | 63 | $8,720 | $840.34 | 9.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 46 | 47 | $940.00 | $138.18 | 14.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 14 | $700.00 | $47.74 | 6.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 540 | 555 | $210,900 | $62,792 | 29.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 47 | 3,600 | $210,300 | $55,338 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 216 | 308 | $80,080 | $24,883 | 31.1% |
About Dr. Lance Edwards, MD
Dr. Lance Edwards, MD is a Gynecology healthcare provider based in Port Jefferson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487638037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Edwards, MD has received a total of $2,095 in payments from pharmaceutical and medical device companies, with $391.87 received in 2024. These payments were reported across 53 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,045).
As a Medicare-enrolled provider, Edwards has provided services to 5,317 Medicare beneficiaries, totaling 17,379 services with total Medicare billing of $637,690. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Port Jefferson, NY
- Active Since 12/06/2005
- Last Updated 10/10/2011
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1487638037
Products in Payments
- EVENITY (Biological) $456.50
- Prolia (Biological) $344.67
- GARDASIL (Biological) $124.92
- Orilissa (Drug) $122.52
- SOLOSEC (Drug) $119.67
- NEXPLANON (Drug) $79.66
- INJECTAFER (Drug) $71.45
- LILETTA (Drug) $56.21
- NUVARING (Drug) $51.32
- Kyleena (Drug) $46.18
- Veozah (Drug) $42.10
- GARDASIL 9 (Biological) $38.50
- QUVIVIQ (Drug) $35.00
- Global Endometrial Abiation (Device) $27.86
- Paragard T 380A (Drug) $26.29
- AHPV trich (Device) $23.64
- ACCRUFER (Drug) $23.23
- INTRAROSA (Drug) $22.88
- Endosee (Device) $21.83
- AHPV (Device) $18.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.